Viewing Study NCT05025735


Ignite Creation Date: 2025-12-24 @ 10:20 PM
Ignite Modification Date: 2025-12-29 @ 2:54 AM
Study NCT ID: NCT05025735
Status: UNKNOWN
Last Update Posted: 2021-10-19
First Post: 2021-06-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer
Sponsor: Saint Luke's Health System
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module